Sugi Predict

Sugi Predict / Compounds / SCHEMBL351579

SCHEMBL351579

SCHEMBL351579

CC(C)(C)c1cc(C(=O)O)on1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.49
▸ GRN P28799 5/20 0.42
▸ SORT1 Q99523 5/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPK14 Q16539 5/20 0.41
▸ CNR2 P34972 1/20 0.40
▸ RAF1 P04049 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GLRA3 O75311 1/20 0.34
▸ GLRB P48167 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ MAPK13 O15264 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL351138 0.82 ALDH1A1 (0.47) HCAR2ALDH1A1GRNSORT1KDM4E
SCHEMBL352169 0.82 ALDH1A1 (0.47) HCAR2ALDH1A1GRNSORT1KDM4E
SCHEMBL10146308 0.82 HCAR2 (0.50) HCAR2ALDH1A1MAPK14CNR2GAA
SCHEMBL2565757 0.80 HCAR2 (0.52) HCAR2ALDH1A1KDM4EMAPK14GAA
SCHEMBL352449 0.79 ALDH1A1 (0.49) HCAR2ALDH1A1MAPK14CNR2RAF1
SCHEMBL27876364 0.78 HCAR2 (0.50) HCAR2ALDH1A1KDM4EMAPK14GAA
SCHEMBL18407336 0.78 ALDH1A1 (0.47) ALDH1A1MAPK14CNR2RAF1
SCHEMBL12747057 0.78 ALDH1A1 (0.47) ALDH1A1KDM4EMAPK14CNR2RAF1
SCHEMBL18407362 0.76 LMNA (0.55) ALDH1A1KDM4EMAPK14RAF1MEN1
SCHEMBL19886210 0.75 ALDH1A1 (0.49) ALDH1A1KDM4EMAPK14CNR2RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069327-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — US claimed
EP-0761654-B1 Isoxazole- and isothiazole-5-carboxamide derivatives, their preparation and their use as herbicides BASF AG (DE) 2003-06-18 — — EP claimed
EP-0761654-A1 Isoxazole- and isothiazole-5-carboxamide derivatives, their preparation and their use as herbicides American Cyanamid Company (US) 1997-03-12 — — EP claimed
EP-3710428-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-25 — — EP disclosed
US-20240307382-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-09-19 — — US disclosed
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 — — US disclosed
CN-112204009-B Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2024-05-07 — — CN disclosed
CN-116981672-A Macrocyclic compounds as CFTR modulators 爱杜西亚药品有限公司 2023-10-31 — — CN disclosed
US-20230257352-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-08-17 — — US disclosed
US-20230257352-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-08-17 — — US disclosed
EP-3452456-B1 BICYCLIC MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2023-07-05 — — EP disclosed
WO-2009140089-A2 SULFONE COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-11-19 — — WO disclosed
US-20090069327-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-03-12 — — US disclosed
WO-2007001335-A2 RAMOPLANIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2007-01-04 — — WO disclosed
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-09-21 — — US disclosed
EP-0761654-B1 Isoxazole- and isothiazole-5-carboxamide derivatives, their preparation and their use as herbicides BASF AG (DE) 2003-06-18 — — EP disclosed
US-5780393-A Herbicidal isoxazole and isothiazole-5-carboxamides AMERICAN CYANAMID COMPANY (US) 1998-07-14 — — US disclosed
EP-0761654-A1 Isoxazole- and isothiazole-5-carboxamide derivatives, their preparation and their use as herbicides American Cyanamid Company (US) 1997-03-12 — — EP disclosed
EP-0399645-B1 Tetrahydropyranyl derivatives, process for their preparation and pharmaceutical or veterinary compositions containing them BEECHAM GROUP PLC (GB) 1994-11-09 — — EP disclosed
EP-0399645-A2 Tetrahydropyranyl derivatives, process for their preparation and pharmaceutical or veterinary compositions containing them BEECHAM GROUP PLC (GB) 1990-11-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257352-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF BRAF, RAF1, ARAF HCAR2 4118/4885ALDH1A1 2049/4885GRN 4037/4885
US-20090069327-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS SRC, BMX, FYN HCAR2 2171/4885ALDH1A1 4462/4885GRN 2897/4885
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS CFTR, PKD1, ARRB1 HCAR2 1198/4885ALDH1A1 2257/4885GRN 2607/4885
US-20240307382-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 HCAR2 2061/4885ALDH1A1 3433/4885GRN 1668/4885
US-20060211603-A1 Ramoplanin derivatives possessing antibacterial activity CLSPN, LMAN2, RPN2 HCAR2 3637/4885ALDH1A1 2972/4885GRN 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.